Lam Research Corp (LRCX) stock saw a modest uptick, ending the day at $80.3 which represents a slight increase of $1.08 or 1.36% from the prior close of $79.22. The stock opened at $81.41 and touched ...

Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.92% of ...

Let’s give a warm Jersey welcome to the visiting polar vortices. That, of course, smacks of insincerity since there’s nothing ...

What started out as a standard city council meeting to kick off the New Year ended in complete chaos, and it was all recorded ...

On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc. (Enigma) announced the signing of a research license and ...

If your idea of a good mystery involves one of the world's most Internet-famous superyachts, we got you covered. Loon, aka MY Loon, dubbed by trade publications last year "the world's most ...

Once we got to know him a little bit, he would come in from time to time and just make prints,” former director of UW-Madison ...

KNOXVILLE, Tenn., January 17, 2025--(BUSINESS WIRE)--On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma ...